- Home
- SWIN vs PULM Comparison
SWIN vs PULM Comparison
Compare SWIN & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- PULM
- Stock Information
- Founded
- SWIN 2017
- PULM 2003
- Country
- SWIN Hong Kong
- PULM United States
- Employees
- SWIN N/A
- PULM N/A
- Industry
- SWIN
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- PULM Health Care
- Exchange
- SWIN Nasdaq
- PULM Nasdaq
- Market Cap
- SWIN 32.1M
- PULM 33.2M
- IPO Year
- SWIN 2023
- PULM N/A
- Fundamental
- Price
- SWIN $3.71
- PULM $6.41
- Analyst Decision
- SWIN
- PULM
- Analyst Count
- SWIN 0
- PULM 0
- Target Price
- SWIN N/A
- PULM N/A
- AVG Volume (30 Days)
- SWIN 283.9K
- PULM 57.7K
- Earning Date
- SWIN 08-21-2025
- PULM 08-12-2025
- Dividend Yield
- SWIN N/A
- PULM N/A
- EPS Growth
- SWIN N/A
- PULM N/A
- EPS
- SWIN N/A
- PULM N/A
- Revenue
- SWIN $3,316,000.00
- PULM $1,921,000.00
- Revenue This Year
- SWIN $29.79
- PULM N/A
- Revenue Next Year
- SWIN $54.60
- PULM $134.88
- P/E Ratio
- SWIN N/A
- PULM N/A
- Revenue Growth
- SWIN N/A
- PULM N/A
- 52 Week Low
- SWIN $1.16
- PULM $1.78
- 52 Week High
- SWIN $4.40
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- SWIN 66.98
- PULM 37.18
- Support Level
- SWIN $2.93
- PULM $6.28
- Resistance Level
- SWIN $3.99
- PULM $6.83
- Average True Range (ATR)
- SWIN 0.44
- PULM 0.35
- MACD
- SWIN -0.01
- PULM -0.07
- Stochastic Oscillator
- SWIN 72.37
- PULM 0.00
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).